Global Skin Biopsy Market: Overview

Skin biopsy is an examination procedure involving skin removal and information on diseases or clinical conditions. The presence of cancer cells or of all skin conditions is determined. Different conditions can be diagnosed via biopsy, such as skin cancer, actinic keratosis, dermatitis, psoriasis and skin infection. The sample from the affected and ill skin section will be placed in the formaldehyde solution during the procedure, the tissue will be processed and examined under a microscope. 

The rapid decline of the ozone layer causes an increase in UV penetration. Increased skin cancer incidences due to long-term exposure to these rays stimulates the development of a global market for skin biopsy. The growing expenditure for medical instruments and the launch of advanced and cost-effective products has a positive impact on the growth of the global market for skin biopsy.

This report gives an in-depth analysis of the global skin biopsy market, focus on market opportunities and challenges, alongside the trends driving the market. The report identifies leading vendors operating in the skin biopsy market, while outlining opportunities available for them.  

Global Skin Biopsy Market: Trends and Opportunities 

The increased demand for minimally invasive medical treatments and the increased number of skin illnesses such as psoriasis, viral skin infection and dermatitis are major contributing factor in growth on the market. In addition, increasing medical equipment and instruments expenditure stimulate market growth. However, the market is restricted by high treatment costs for skin diseases. 

In addition, the increase in the geriatric population and the tendency to reduce the invasion of the skin biopsy market are some of the crucial factors driving the growth. 

Global Skin Biopsy Market: Regional Outlook 

The Americas account for the world's largest market share of skin biopsy, due to the increasing prevalence of skin diseases and the presence in this region of a large pool of players. As the demand for technologically advanced and less invasive diagnostic procedures is growing in this region, the European region is the second-largest share on the skin biopsy market.   

Asia- Pacific is anticipated to project the fastest growth in the global market for skin biopsy due to increased investment by integrating advanced technologies and increasing the incidence of cancer and diseases of the skin in the emerging economies such as India and China. 

Global Skin Biopsy Market: Competitive Landscape 

The high demand for technologically advanced and less invasive diagnostic procedures has created many opportunities for players to invest in the global skin biopsy market. Strengthens competition between the global skin biopsy market players by high investment in research and development. 

Leading vendors operating in the global skin biopsy market are Cook Medical, DTR Medical Ltd, Devicor Medical Products, Inc., Boston Scientific Corporation, Cardinal Health, and Hologic, Inc. 

Market segmentation based on geography: 

  • North America
  • South America
  • Europe
  • Asia Pacific
  • Middle East and Africa 

This report gives access to decisive data, such as: 

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for the coming years 

Key highlights of this report include: 

  • Overview of key market forces propelling and restraining market growth
  • Up-to-date analyses of market trends and technological improvements
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors
  • An array of graphics and SWOT analysis of major industry segments
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis
  • Offers a clear understanding of the competitive landscape and key product segments

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.